Skip to main content

Table 3 Toxicities by HSCT and infection

From: Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China

Toxicity HLA-matched HSCT Haploidentical HSCT P
Hepatic
 Transaminase elevation 8(22.9 %) 14(29.8 %) 0.484
 Bilirubin elevation 3(8.6 %) 9(19.1 %) 0.180
Gastrointestinal tract
 Diarrhea 25(71.4 %) 33(70.2) 0.905
 Nausea and vomiting 17(48.6 %) 32(68.1 %) 0.075
 Mucositis 13(37.1 %) 21(44.7 %) 0.493
 Alimentary tract hemorrhage 2(5.7 %) 6(12.8) 0.287
Urinary tract/kidney
 Creatinine elevation 0 1(2.1) 0.385
 Hemorrhagic cystitis 1(2.9 %) 1 0.832
Infection
 Bacterial infection 23(65.7 %) 32(68.1 %) 0.821
 Fungal infection 4(11.4 %) 8(17.0 %) 0.479
 CMV infection 5(14.3 %) 18(38.3 %) 0.017
Cardiovascular
 Heart dysfunction 1 0 0.244
  1. CMV cytomegalovirus